CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 40 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $121,000 | -28.0% | 33,968 | -19.1% | 0.00% | -50.0% |
| Q3 2020 | $168,000 | -21.5% | 41,968 | -46.6% | 0.00% | 0.0% |
| Q2 2020 | $214,000 | +28.9% | 78,634 | +0.1% | 0.00% | 0.0% |
| Q1 2020 | $166,000 | -59.8% | 78,576 | +3.4% | 0.00% | -50.0% |
| Q4 2019 | $413,000 | +220.2% | 75,996 | +76.7% | 0.00% | +100.0% |
| Q3 2019 | $129,000 | -42.2% | 43,017 | -28.0% | 0.00% | -33.3% |
| Q2 2019 | $223,000 | +8.3% | 59,718 | +6.3% | 0.00% | -25.0% |
| Q4 2018 | $206,000 | -45.2% | 56,174 | +28.3% | 0.00% | -20.0% |
| Q3 2018 | $376,000 | +159.3% | 43,774 | +212.1% | 0.01% | +66.7% |
| Q4 2017 | $145,000 | – | 14,026 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $8,746,000 | 1.82% |
| Telemetry Investments, L.L.C. | 263,975 | $705,000 | 0.97% |
| CHI Advisors LLC | 719,132 | $1,920,000 | 0.45% |
| BVF INC/IL | 3,678,626 | $9,822,000 | 0.37% |
| EcoR1 Capital, LLC | 3,579,377 | $9,557,000 | 0.36% |
| Orbimed Advisors | 8,053,298 | $21,502,000 | 0.22% |
| Stonepine Capital Management, LLC | 46,886 | $125,000 | 0.06% |
| Ikarian Capital, LLC | 100,000 | $267,000 | 0.02% |
| ALGERT GLOBAL LLC | 19,737 | $53,000 | 0.02% |
| Windsor Creek Advisors, LLC | 14,786 | $39,000 | 0.01% |